KA/EN
Register
Medicines reference
Search
Search
Product

Biocan Puppy

Favourites

Canine distemper virus + Canine parvovirus · Bioveta, a.s.

1 form: suspension. In force in Georgia: 1 of 1 (veterinary register).

Forms and doses1 of 1 in force in Georgia

The dose from the product's label, by species and weight. Check the label of the pack you use.

Form Species Dose Frequency Georgia
Suspension · Dog Dog 1 ml (1 ml)
Aseptically reconstitute with the suspension, shake and immediately inject the entire 1 ml dose SC. Give two doses 2-3 weeks apart from five weeks. Annual Biocan Puppy revaccination is appropriate when only CDV and CPV protection is needed. Vaccinate healthy dogs only. Antiparasitic treatment should precede vaccination by at least 10 days and strenuous work is discouraged for one week. Very rare pea-sized local reaction may last up to three weeks; very rare hypersensitivity requires symptomatic treatment. Pregnancy and lactation safety is not established. Other medicines require case-by-case assessment. Store 2-8 C, do not freeze, protect from light and use immediately after reconstitution.
 · two doses 2-3 weeks apart from 5 weeks; then annually when CDV and CPV-only protection is required		 two doses 2-3 weeks apart from 5 weeks; then annually when CDV and CPV-only protection is required Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ბიოკან პუპი - ჭირისა და პარვოვირუსის საწინააღმდეგო ინაქტივირებული ვაქცინა
№ 185-11
Verified on: 21 Oct 2026
Details: pack, label wording, sources, registration

Biocan Puppy, Suspension

lyophilisate and suspension, 1 ml dose for dogs
vetman assessment
vetman’s 10-point assessment brings together a product’s regulatory credibility, clinical efficacy, safety and practicality. Cost-effectiveness is assessed only when reliable data are available. It is informational and does not replace a veterinarian’s clinical judgment for an individual patient.
Dog
7.6/10
Good
vetman assessment

Biocan Puppy

lyophilisate and suspension, 1 ml dose for dogs
Assessed clinical scopeDog · Full dog label from 5 weeks: early immunisation against distemper (live CDV) and parvovirus (inactivated CPV) · Subcutaneous
Care settingEarly puppy vaccination in a clinic as a bridge to a full core programme, with a documented follow-up plan
vetman score 7.6/10 Good
Evidence confidence: Medium Georgia: Yes, veterinary · № 185-11 · Verified on 21 Oct 2026

A good early distemper and parvovirus bridge for young puppies in high-risk settings. Its inactivated parvovirus component is weaker against maternal antibody than modern live CPV vaccines, so complete the core series with a full polyvalent vaccine.

Regulatory and scientific credibility8.5/10

The exact presentation is registered in Georgia (185-11) and in Czechia since 2004 (97/011/04-C) with a current public SPC, but public independent evidence on this formulation is limited.

Clinical efficacy6.5/10

CDV and CPV are essential targets, but the parvovirus component is inactivated; WSAVA prefers modified-live CPV because inactivated CPV is less able to overcome maternal antibody, and onset is slow at 14-28 days.

Safety and tolerability8.0/10

Only very rare local or hypersensitivity reactions are labelled; safety in pregnancy and lactation is not established.

Clinical practicality7.0/10

The fixed 1 ml dose is simple, but it covers only two diseases and needs a planned polyvalent follow-up, reconstitution and immediate use.

Full-course cost-effectiveness-

No verified current Georgian price or patient-adjusted course cost was found; foreign prices were not substituted.

Important safety and use flags

  • This is a two-antigen bridge, not a complete core vaccine: it contains no adenovirus and no parainfluenza, leptospirosis or rabies antigen. Continue with a polyvalent core vaccine.
  • The parvovirus component is inactivated and immunity develops 14-28 days after the primary course. Maternal antibody can block it; finish the core series at 16 weeks or later with a live CPV vaccine.
  • Annual revaccination with this product alone is only appropriate when protection against CDV and CPV only is wanted.
  • Give antiparasitic treatment at least 10 days before vaccination and avoid strenuous exercise for a week after it. Observe for rare local or hypersensitivity reactions.
  • Safety in pregnancy and lactation is not established.
  • Store at 2-8 C, do not freeze, protect from light and inject the whole reconstituted 1 ml immediately.
Assessment sources
  1. EU UPD SPC 20262026
  2. Georgia NFA register 20262026
  3. WSAVA vaccination 20242024
  4. AAHA canine vaccination 20222022
Assessed: 23 Oct 2026The overall score uses 25/25/25/15/10 weights. An unassessed price is excluded and the remaining weights are proportionally renormalised.
Composition / strength
Canine distemper virus4.2 log10 TCID50/dose Canine parvovirus1024 HAU/dose
Formulation Type
Suspension
Administration route
Subcutaneous
Manufacturer
Bioveta, a.s. · Czechia
Registration
Georgia Yes, veterinary
Veterinary (National Food Agency)
In the register: ბიოკან პუპი - ჭირისა და პარვოვირუსის საწინააღმდეგო ინაქტივირებული ვაქცინა
№ 185-11
Verified on: 21 Oct 2026
 EU Yes, veterinary
№ CZ 97/011/04-C
Verified on: 23 Oct 2026
Controlled in Georgia
Unknown
DoseSpeciesWeightRouteFrequencySource
1 ml (1 ml)
Aseptically reconstitute with the suspension, shake and immediately inject the entire 1 ml dose SC. Give two doses 2-3 weeks apart from five weeks. Annual Biocan Puppy revaccination is appropriate when only CDV and CPV protection is needed. Vaccinate healthy dogs only. Antiparasitic treatment should precede vaccination by at least 10 days and strenuous work is discouraged for one week. Very rare pea-sized local reaction may last up to three weeks; very rare hypersensitivity requires symptomatic treatment. Pregnancy and lactation safety is not established. Other medicines require case-by-case assessment. Store 2-8 C, do not freeze, protect from light and use immediately after reconstitution.
 Dog Any weight Subcutaneous two doses 2-3 weeks apart from 5 weeks; then annually when CDV and CPV-only protection is required
EU UPD SPC 2026
Official product label (SPC)
Approved by a medicines regulator as part of the product's authorisation. It applies to that product as authorised there.
Biocan Puppy - official SPC
EU Union Product Database, 2026

Canine distemper virus: No dose supported by a publicly verifiable source yet

Canine parvovirus: No dose supported by a publicly verifiable source yet

Products are connected by name, active ingredients, or therapeutic group. They are not direct substitutes for one another.

Show all related products (3 more) Hide additional products

Same product line 1

Same active ingredients 2

Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.

For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.

Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.

The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.

This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026

All of this shows in vetman as you prescribe

The dose for the patient's weight, registration in Georgia and controlled status, right on the prescription.

Register Demo ↗